Who owns TAKEDA PHARMACEUTICAL CO LTD, from the filings themselves: stakes over 5% (Schedule 13D/G), the institutional managers reporting the stock each quarter (13F), and the funds holding it (N-PORT).
Investors crossing 5% ownership must disclose it. Schedule 13G filers certify the stake is passive; Schedule 13D is the general form for everyone else — founders, strategic holders, and activists alike. Each entry is the holder's most recent disclosure. Coverage begins with SEC's structured filings from December 18, 2024; a holder appears once they file or amend after that date.
No 13D/13G disclosures on record for TAKEDA PHARMACEUTICAL CO LTD.
No holder has disclosed crossing the 5% threshold in filings since December 18, 2024, when our coverage begins.
Every institutional manager whose latest 13F reports this stock, largest position first. "% of their portfolio" is the weight inside that manager's own book — how much conviction the position represents; "% of company" is how much of TAKEDA PHARMACEUTICAL CO LTD they hold.
| Investor | Position value | Shares | % of their portfolio | % of company | As of |
|---|---|---|---|---|---|
| LPL Financial LLC | $2.28B | 66,011,485 | 0.51% | — | June 30, 2026 |
| RAYMOND JAMES FINANCIAL INC | $582M | 14,777,805 | 0.16% | — | June 30, 2026 |
1,045 more institutional holders behind a free account
See every manager reporting TAKEDA PHARMACEUTICAL CO LTD, how much of the company they hold, and how big the position is inside their own portfolio.
Sign up freeFunds disclosing this stock in their monthly N-PORT portfolio, with the position's share of the fund's net assets.
| Fund | Position value | % of net assets | % of company | As of |
|---|---|---|---|---|
| American Mutual Fund | $303M | 0.26% | — | April 30, 2026 |
| State Street(R) Fixed Income Sector Rotation ETF | $71.5M | 15.68% | — | March 31, 2026 |
43 more funds behind a free account
See every fund holding TAKEDA PHARMACEUTICAL CO LTD and what share of its net assets the position represents.
Sign up freeLoading...
